{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["coffee", "diabetes", "rats", "skeletal system", "streptozotocin", "trigonelline"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26950142", "DateCompleted": {"Year": "2016", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "03", "Day": "02"}], "ELocationID": ["133", "10.3390/nu8030133"], "Language": ["eng"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "8", "Issue": "3", "PubDate": {"Year": "2016", "Month": "Mar", "Day": "02"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Effects of Trigonelline, an Alkaloid Present in Coffee, on Diabetes-Induced Disorders in the Rat Skeletal System.", "Pagination": {"StartPage": "133", "MedlinePgn": "133"}, "Abstract": {"AbstractText": ["Diabetes increases bone fracture risk. Trigonelline, an alkaloid with potential antidiabetic activity, is present in considerable amounts in coffee. The aim of the study was to investigate the effects of trigonelline on experimental diabetes-induced disorders in the rat skeletal system. Effects of trigonelline (50 mg/kg p.o. daily for four weeks) were investigated in three-month-old female Wistar rats, which, two weeks before the start of trigonelline administration, received streptozotocin (60 mg/kg i.p.) or streptozotocin after nicotinamide (230 mg/kg i.p.). Serum bone turnover markers, bone mineralization, and mechanical properties were studied. Streptozotocin induced diabetes, with significant worsening of bone mineralization and bone mechanical properties. Streptozotocin after nicotinamide induced slight glycemia increases in first days of experiment only, however worsening of cancellous bone mechanical properties and decreased vertebral bone mineral density (BMD) were demonstrated. Trigonelline decreased bone mineralization and tended to worsen bone mechanical properties in streptozotocin-induced diabetic rats. In nicotinamide/streptozotocin-treated rats, trigonelline significantly increased BMD and tended to improve cancellous bone strength. Trigonelline differentially affected the skeletal system of rats with streptozotocin-induced metabolic disorders, intensifying the osteoporotic changes in streptozotocin-treated rats and favorably affecting bones in the non-hyperglycemic (nicotinamide/streptozotocin-treated) rats. The results indicate that, in certain conditions, trigonelline may damage bone."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Pharmacy with the Division of Laboratory Medicine, Medical University of Silesia, 40-055 Katowice, Poland. jfolwarczna@sum.edu.pl."}], "LastName": "Folwarczna", "ForeName": "Joanna", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Pharmacy with the Division of Laboratory Medicine, Medical University of Silesia, 40-055 Katowice, Poland. ajanas@sum.edu.pl."}], "LastName": "Janas", "ForeName": "Aleksandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Pharmacy with the Division of Laboratory Medicine, Medical University of Silesia, 40-055 Katowice, Poland. mariapytlik@gmail.com."}], "LastName": "Pytlik", "ForeName": "Maria", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Pharmacy with the Division of Laboratory Medicine, Medical University of Silesia, 40-055 Katowice, Poland. ucegiela@o2.pl."}], "LastName": "Cegie\u0142a", "ForeName": "Urszula", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Pharmacy with the Division of Laboratory Medicine, Medical University of Silesia, 40-055 Katowice, Poland. lsliw@o2.pl."}], "LastName": "\u015aliwi\u0144ski", "ForeName": "Leszek", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical and Experimental Pharmacotherapy, Medical Faculty, Slovak Medical University, 833 03 Bratislava, Slovakia. zora.krivosikova@szu.sk."}], "LastName": "Krivo\u0161\u00edkov\u00e1", "ForeName": "Zora", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical and Experimental Pharmacotherapy, Medical Faculty, Slovak Medical University, 833 03 Bratislava, Slovakia. kornelia.stefikova@szu.sk."}], "LastName": "\u0160tef\u00edkov\u00e1", "ForeName": "Korn\u00e9lia", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical and Experimental Pharmacotherapy, Medical Faculty, Slovak Medical University, 833 03 Bratislava, Slovakia. martin.gajdos@szu.sk."}], "LastName": "Gajdo\u0161", "ForeName": "Martin", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "25X51I8RD4", "NameOfSubstance": "Niacinamide"}, {"RegistryNumber": "3NQ9N60I00", "NameOfSubstance": "trigonelline"}, {"RegistryNumber": "5W494URQ81", "NameOfSubstance": "Streptozocin"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "toxicity"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["blood"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bone Density"}, {"QualifierName": ["chemistry"], "DescriptorName": "Coffea"}, {"QualifierName": ["blood", "chemically induced", "physiopathology"], "DescriptorName": "Diabetes Complications"}, {"QualifierName": ["blood", "chemically induced", "drug therapy"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": ["blood", "chemically induced", "drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 1"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects", "physiopathology"], "DescriptorName": "Femur"}, {"QualifierName": ["isolation & purification", "toxicity"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["drug effects", "physiopathology"], "DescriptorName": "Lumbar Vertebrae"}, {"QualifierName": [], "DescriptorName": "Niacinamide"}, {"QualifierName": ["blood", "chemically induced", "physiopathology"], "DescriptorName": "Osteoporosis"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "toxicity"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Risk Assessment"}, {"QualifierName": [], "DescriptorName": "Seeds"}, {"QualifierName": [], "DescriptorName": "Streptozocin"}, {"QualifierName": ["drug effects", "physiopathology"], "DescriptorName": "Tibia"}, {"QualifierName": [], "DescriptorName": "Weight-Bearing"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "American Diabetes Association 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl. 1):S8\u2013S16.", "ArticleIdList": ["25537714"]}, {"Citation": "Yan W., Li X. Impact of diabetes and its treatments on skeletal diseases. Front. Med. 2013;7:81\u201390. doi: 10.1007/s11684-013-0243-9.", "ArticleIdList": ["10.1007/s11684-013-0243-9", "23377889"]}, {"Citation": "Starup-Linde J., Vestergaard P. Management of endocrine disease: Diabetes and osteoporosis: Cause for concern? Eur. J. Endocrinol. 2015;173:R93\u2013R99. doi: 10.1530/EJE-15-0155.", "ArticleIdList": ["10.1530/EJE-15-0155", "26243638"]}, {"Citation": "Beaudoin M.S., Graham T.E. Methylxanthines and human health: Epidemiological and experimental evidence. Handb. Exp. Pharmacol. 2011;200:509\u2013548.", "ArticleIdList": ["20859811"]}, {"Citation": "Jiang X., Zhang D., Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: A meta-analysis of prospective studies. Eur. J. Nutr. 2014;53:25\u201338. doi: 10.1007/s00394-013-0603-x.", "ArticleIdList": ["10.1007/s00394-013-0603-x", "24150256"]}, {"Citation": "Higdon J.V., Frei B. Coffee and health: A review of recent human research. Crit. Rev. Food Sci. Nutr. 2006;46:101\u2013123. doi: 10.1080/10408390500400009.", "ArticleIdList": ["10.1080/10408390500400009", "16507475"]}, {"Citation": "Cano-Marquina A., Tar\u00edn J.J., Cano A. The impact of coffee on health. Maturitas. 2013;75:7\u201321. doi: 10.1016/j.maturitas.2013.02.002.", "ArticleIdList": ["10.1016/j.maturitas.2013.02.002", "23465359"]}, {"Citation": "Lee D.R., Lee J., Rota M., Lee J., Ahn H.S., Park S.M., Shin D. Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis. Bone. 2014;63:20\u201328. doi: 10.1016/j.bone.2014.02.007.", "ArticleIdList": ["10.1016/j.bone.2014.02.007", "24576685"]}, {"Citation": "Li S., Dai Z., Wu Q. Effect of coffee intake on hip fracture: A meta-analysis of prospective cohort studies. Nutr. J. 2015;14:38. doi: 10.1186/s12937-015-0025-0.", "ArticleIdList": ["10.1186/s12937-015-0025-0", "PMC4412140", "25928220"]}, {"Citation": "Perrone D., Donangelo C.M., Farah A. Fast simultaneous analysis of caffeine, trigonelline, nicotinic acid and sucrose in coffee by liquid chromatography-mass spectrometry. Food Chem. 2008;110:1030\u20131035. doi: 10.1016/j.foodchem.2008.03.012.", "ArticleIdList": ["10.1016/j.foodchem.2008.03.012", "26047298"]}, {"Citation": "Do Carmo Carvalho D., Brigag\u00e3o M.R., dos Santos M.H., de Paula F.B., Giusti-Paiva A., Azevedo L. Organic and conventional Coffea arabica L.: A comparative study of the chemical composition and physiological, biochemical and toxicological effects in Wistar rats. Plant Foods Hum. Nutr. 2011;66:114\u2013121. doi: 10.1007/s11130-011-0221-9.", "ArticleIdList": ["10.1007/s11130-011-0221-9", "21523414"]}, {"Citation": "Rodrigues N.P., Salva T.J.G., Bragagnolo N. Influence of coffee genotype on bioactive compounds and the in vitro capacity to scavenge reactive oxygen and nitrogen species. J. Agric. Food Chem. 2015;63:4815\u20134826. doi: 10.1021/acs.jafc.5b00530.", "ArticleIdList": ["10.1021/acs.jafc.5b00530", "25910038"]}, {"Citation": "Yadav U.C., Baquer N.Z. Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm. Biol. 2014;52:243\u2013254. doi: 10.3109/13880209.2013.826247.", "ArticleIdList": ["10.3109/13880209.2013.826247", "24102093"]}, {"Citation": "Zhou J., Chan L., Zhou S. Trigonelline: A plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr. Med. Chem. 2012;19:3523\u20133531. doi: 10.2174/092986712801323171.", "ArticleIdList": ["10.2174/092986712801323171", "22680628"]}, {"Citation": "Folwarczna J., Zych M., Nowi\u0144ska B., Pytlik M., Janas A. Unfavorable effect of trigonelline, an alkaloid present in coffee and fenugreek, on bone mechanical properties in estrogen-deficient rats. Mol. Nutr. Food Res. 2014;58:1457\u20131464. doi: 10.1002/mnfr.201300936.", "ArticleIdList": ["10.1002/mnfr.201300936", "24867387"]}, {"Citation": "Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 2001;50:537\u2013546.", "ArticleIdList": ["11829314"]}, {"Citation": "Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D., Novelli M., Ribes G. Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47:224\u2013229. doi: 10.2337/diab.47.2.224.", "ArticleIdList": ["10.2337/diab.47.2.224", "9519717"]}, {"Citation": "Folwarczna J., Pytlik M., Zych M., Cegie\u0142a U., Kaczmarczyk-Sedlak I., Nowi\u0144ska B., \u015aliwi\u0144ski L. Favorable effect of moderate dose caffeine on the skeletal system in ovariectomized rats. Mol. Nutr. Food Res. 2013;57:1772\u20131784. doi: 10.1002/mnfr.201300123.", "ArticleIdList": ["10.1002/mnfr.201300123", "23754597"]}, {"Citation": "Folwarczna J., Zych M., Trzeciak H.I. Effects of curcumin on the skeletal system in rats. Pharmacol. Rep. 2010;62:900\u2013909. doi: 10.1016/S1734-1140(10)70350-9.", "ArticleIdList": ["10.1016/S1734-1140(10)70350-9", "21098873"]}, {"Citation": "Turner C.H., Burr D.B. Basic biomechanical measurements of bone: A tutorial. Bone. 1993;14:595\u2013608. doi: 10.1016/8756-3282(93)90081-K.", "ArticleIdList": ["10.1016/8756-3282(93)90081-K", "8274302"]}, {"Citation": "St\u00fcrmer E.K., Seidlov\u00e1-Wuttke D., Sehmisch S., Rack T., Wille J., Frosch K.H., Wuttke W., St\u00fcrmer K.M. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: Effect of estradiol, testosterone, and raloxifene. J. Bone Miner. Res. 2006;21:89\u201396. doi: 10.1359/JBMR.050913.", "ArticleIdList": ["10.1359/JBMR.050913", "16355277"]}, {"Citation": "Khan T.S., Fraser L.A. Type 1 diabetes and osteoporosis: From molecular pathways to bone phenotype. J. Osteoporos. 2015;2015:174186. doi: 10.1155/2015/174186.", "ArticleIdList": ["10.1155/2015/174186", "PMC4385591", "25874154"]}, {"Citation": "Shanbhogue V.V., Mitchell D.M., Rosen C.J., Bouxsein M.L. Type 2 diabetes and the skeleton: New insights into sweet bones. Lancet Diabetes Endocrinol. 2016;4:159\u2013173. doi: 10.1016/S2213-8587(15)00283-1.", "ArticleIdList": ["10.1016/S2213-8587(15)00283-1", "26365605"]}, {"Citation": "Oei L., Rivadeneira F., Zillikens M.C., Oei E.H. Diabetes, diabetic complications, and fracture risk. Curr. Osteoporos. Rep. 2015;13:106\u2013115. doi: 10.1007/s11914-015-0260-5.", "ArticleIdList": ["10.1007/s11914-015-0260-5", "PMC4352609", "25648962"]}, {"Citation": "Maiese K. New insights for oxidative stress and diabetes mellitus. Oxid. Med. Cell Longev. 2015;2015:875961. doi: 10.1155/2015/875961.", "ArticleIdList": ["10.1155/2015/875961", "PMC4443788", "26064426"]}, {"Citation": "Manolagas S.C. From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 2010;31:266\u2013300. doi: 10.1210/er.2009-0024.", "ArticleIdList": ["10.1210/er.2009-0024", "PMC3365845", "20051526"]}, {"Citation": "Meier C., Schwartz A.V., Egger A., Lecka-Czernik B. Effects of diabetes drugs on the skeleton. Bone. 2016;82:93\u2013100. doi: 10.1016/j.bone.2015.04.026.", "ArticleIdList": ["10.1016/j.bone.2015.04.026", "25913633"]}, {"Citation": "Silva M.J., Brodt M.D., Lynch M.A., McKenzie J.A., Tanouye K.M., Nyman J.S., Wang X. Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J. Bone Miner. Res. 2009;24:1618\u20131627. doi: 10.1359/jbmr.090316.", "ArticleIdList": ["10.1359/jbmr.090316", "PMC2730931", "19338453"]}, {"Citation": "Erdal N., G\u00fcrg\u00fcl S., Demirel C., Yildiz A. The effect of insulin therapy on biomechanical deterioration of bone in streptozotocin (STZ)-induced type 1 diabetes mellitus in rats. Diabetes Res. Clin. Pract. 2012;97:461\u2013467. doi: 10.1016/j.diabres.2012.03.005.", "ArticleIdList": ["10.1016/j.diabres.2012.03.005", "22483749"]}, {"Citation": "Coe L.M., Zhang J., McCabe L.R. Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice. J. Cell. Physiol. 2013;228:689\u2013695. doi: 10.1002/jcp.24177.", "ArticleIdList": ["10.1002/jcp.24177", "22886636"]}, {"Citation": "Thrailkill K.M., Clay Bunn R., Nyman J.S., Rettiganti M.R., Cockrell G.E., Wahl E.C., Uppuganti S., Lumpkin C.K., Jr., Fowlkes J.L. SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice. Bone. 2016;82:101\u2013107. doi: 10.1016/j.bone.2015.07.025.", "ArticleIdList": ["10.1016/j.bone.2015.07.025", "PMC4679447", "26211996"]}, {"Citation": "Masiello P. Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int. J. Biochem. Cell Biol. 2006;38:873\u2013893. doi: 10.1016/j.biocel.2005.09.007.", "ArticleIdList": ["10.1016/j.biocel.2005.09.007", "16253543"]}, {"Citation": "Szkudelski T., Zywert A., Szkudelska K. Metabolic disturbances and defects in insulin secretion in rats with streptozotocin-nicotinamide-induced diabetes. Physiol. Res. 2013;62:663\u2013670.", "ArticleIdList": ["23869889"]}, {"Citation": "Wei J., Ferron M., Clarke C.J., Hannun Y.A., Jiang H., Blaner W.S., Karsenty G. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J. Clin. Investig. 2014;124:1\u201313. doi: 10.1172/JCI72323.", "ArticleIdList": ["10.1172/JCI72323", "PMC3973090", "24642469"]}, {"Citation": "Ferron M., Lacombe J. Regulation of energy metabolism by the skeleton: Osteocalcin and beyond. Arch. Biochem. Biophys. 2014;561:137\u2013146. doi: 10.1016/j.abb.2014.05.022.", "ArticleIdList": ["10.1016/j.abb.2014.05.022", "24893146"]}, {"Citation": "Hamden K., Bengara A., Amri Z., Elfeki A. Experimental diabetes treated with trigonelline: Effect on key enzymes related to diabetes and hypertension, \u03b2-cell and liver function. Mol. Cell. Biochem. 2013;381:85\u201394. doi: 10.1007/s11010-013-1690-y.", "ArticleIdList": ["10.1007/s11010-013-1690-y", "23754616"]}, {"Citation": "Zhou J., Zhou S., Zeng S. Experimental diabetes treated with trigonelline: Effect on \u03b2 cell and pancreatic oxidative parameters. Fundam. Clin. Pharmacol. 2013;27:279\u2013287. doi: 10.1111/j.1472-8206.2011.01022.x.", "ArticleIdList": ["10.1111/j.1472-8206.2011.01022.x", "22172053"]}, {"Citation": "Kamble H.V., Bodhankar S.L. Cardioprotective effect of concomitant administration of trigonelline and sitagliptin on cardiac biomarkers, lipid levels, electrocardiographic and heamodynamic modulation on cardiomyopathy in diabetic Wistar rats. Biomed. Aging Pathol. 2014;4:335\u2013342. doi: 10.1016/j.biomag.2014.07.009.", "ArticleIdList": ["10.1016/j.biomag.2014.07.009"]}, {"Citation": "Cheng Z.X., Wu J.J., Liu Z.Q., Lin N. Development of a hydrophilic interaction chromatography-UPLC assay to determine trigonelline in rat plasma and its application in a pharmacokinetic study. Chin. J. Nat. Med. 2013;11:164\u2013170. doi: 10.3724/SP.J.1009.2013.00164.", "ArticleIdList": ["10.3724/SP.J.1009.2013.00164", "23787184"]}, {"Citation": "Callaway D.A., Jiang J.X. Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases. J. Bone Miner Metab. 2015;33:359\u2013370. doi: 10.1007/s00774-015-0656-4.", "ArticleIdList": ["10.1007/s00774-015-0656-4", "25804315"]}, {"Citation": "Saito M., Kida Y., Kato S., Marumo K. Diabetes, collagen, and bone quality. Curr. Osteoporos. Rep. 2014;12:181\u2013188. doi: 10.1007/s11914-014-0202-7.", "ArticleIdList": ["10.1007/s11914-014-0202-7", "24623537"]}, {"Citation": "Kowluru R.A., Mishra M. Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim. Biophys. Acta. 2015;1852:2474\u20132483. doi: 10.1016/j.bbadis.2015.08.001.", "ArticleIdList": ["10.1016/j.bbadis.2015.08.001", "26248057"]}, {"Citation": "Yoshinari O., Takenake A., Igarashi K. Trigonelline ameliorates oxidative stress in type 2 diabetic Goto-Kakizaki rats. J. Med. Food. 2013;16:34\u201341. doi: 10.1089/jmf.2012.2311.", "ArticleIdList": ["10.1089/jmf.2012.2311", "23256445"]}, {"Citation": "Ghule A.E., Jadhav S.S., Bodhankar S.L. Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats. Int. Immunopharmacol. 2012;14:740\u2013748. doi: 10.1016/j.intimp.2012.10.004.", "ArticleIdList": ["10.1016/j.intimp.2012.10.004", "23102665"]}, {"Citation": "Tharaheswari M., Jayachandra Reddy N., Kumar R., Varshney K.C., Kannan M., Sudha Rani S. Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPAR\u03b3 activity in type 2 diabetic rats. Mol. Cell. Biochem. 2014;396:161\u2013714. doi: 10.1007/s11010-014-2152-x.", "ArticleIdList": ["10.1007/s11010-014-2152-x", "25070833"]}, {"Citation": "Boettler U., Sommerfeld K., Volz N., Pahlke G., Teller N., Somoza V., Lang R., Hofmann T., Marko D. Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J. Nutr. Biochem. 2011;22:426\u2013440. doi: 10.1016/j.jnutbio.2010.03.011.", "ArticleIdList": ["10.1016/j.jnutbio.2010.03.011", "20655719"]}, {"Citation": "Abdo S., Shi Y., Otoukesh A., Ghosh A., Lo C.S., Chenier I., Filep J.G., Ingelfinger J.R., Zhang S.L., Chan J.S. Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice. Diabetes. 2014;63:3483\u20133496.", "ArticleIdList": ["PMC4171660", "24812425"]}, {"Citation": "Barroso E., Rodr\u00edguez-Rodr\u00edguez R., Chac\u00f3n M.R., Maym\u00f3-Masip E., Ferrer L., Salvad\u00f3 L., Salmer\u00f3n E., Wabistch M., Palomer X., Vendrell J., et al. PPAR\u03b2/\u03b4 ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation. Biochim. Biophys. Acta. 2015;1852:1049\u20131058. doi: 10.1016/j.bbadis.2015.02.010.", "ArticleIdList": ["10.1016/j.bbadis.2015.02.010", "25728706"]}, {"Citation": "Kumar H., Kim I.S., More S.V., Kim B.W., Choi D.K. Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat. Prod. Rep. 2014;31:109\u2013139. doi: 10.1039/C3NP70065H.", "ArticleIdList": ["10.1039/C3NP70065H", "24292194"]}, {"Citation": "Hybertson B.M., Gao B. Role of the Nrf2 signaling system in health and disease. Clin. Genet. 2014;86:447\u2013452. doi: 10.1111/cge.12474.", "ArticleIdList": ["10.1111/cge.12474", "25099075"]}, {"Citation": "Ilavenil S., Arasu M.V., Lee J.C., Kim D.H., Roh S.G., Park H.S., Choi G.J., Mayakrishnan V., Choi K.C. Trigonelline attenuates the adipocyte differentiation and lipid accumulation in 3T3-L1 cells. Phytomedicine. 2014;21:758\u2013765. doi: 10.1016/j.phymed.2013.11.007.", "ArticleIdList": ["10.1016/j.phymed.2013.11.007", "24369814"]}, {"Citation": "Allred K.F., Yackley K.M., Vanamala J., Allred C.D. Trigonelline is a novel phytoestrogen in coffee beans. J. Nutr. 2009;139:1833\u20131838. doi: 10.3945/jn.109.108001.", "ArticleIdList": ["10.3945/jn.109.108001", "19710155"]}, {"Citation": "Lang R., Dieminger N., Beusch A., Lee Y.M., Dunkel A., Suess B., Skurk T., Wahl A., Hauner H., Hofmann T. Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal. Bioanal. Chem. 2013;405:8487\u20138503. doi: 10.1007/s00216-013-7288-0.", "ArticleIdList": ["10.1007/s00216-013-7288-0", "23982107"]}, {"Citation": "Lang R., Wahl A., Stark T., Hofmann T. Urinary N-methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption. Mol. Nutr. Food Res. 2011;55:1613\u20131623. doi: 10.1002/mnfr.201000656.", "ArticleIdList": ["10.1002/mnfr.201000656", "21618426"]}, {"Citation": "Nawrot P., Jordan S., Eastwood J., Rotstein J., Hugenholtz A., Feeley M. Effects of caffeine on human health. Food Addit. Contam. 2003;20:1\u201330. doi: 10.1080/0265203021000007840.", "ArticleIdList": ["10.1080/0265203021000007840", "12519715"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "12", "Day": "17"}, {"Year": "2016", "Month": "2", "Day": "11"}, {"Year": "2016", "Month": "2", "Day": "23"}, {"Year": "2016", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["26950142", "PMC4808862", "10.3390/nu8030133", "nu8030133"]}}], "PubmedBookArticle": []}